A B S T R A C T
Background: The importance of engaging key stakeholders, and patients in particular, in determining research priorities has been recognized. We sought to identify the top 10 research priorities for patients with non-dialysis chronic kidney disease (CKD), their caregivers, and the clinicians and policy-makers involved in their care. Methods: We used the four-step James Lind Alliance process to establish the top 10 research priorities. A national survey of patients with non-dialysis CKD (estimated glomerular filtration rate <45 mL/min/1.73 m 2 ), their caregivers, and the clinicians and policy-makers involved in their care was conducted to identify research uncertainties. A Steering Group of patients, caregivers, clinicians and researchers combined and reduced these uncertainties to 30 through a series of iterations. Finally, a workshop with participants from across Canada (12 patients, 6 caregivers, 3 physicians, 2 nurses, 1 pharmacist and 1 policy-maker) was held to determine the top 10 research priorities, using a nominal group technique. Results: Overall, 439 individuals responded to the survey and identified 1811 uncertainties, from which the steering group determined the top 30 uncertainties to be considered at the workshop. The top 10 research uncertainties prioritized at the workshop included questions about treatments to prevent progression of kidney disease (including diet) and to treat symptoms of CKD, provider-and patient-targeted strategies for managing CKD, the impact of lifestyle on disease progression, harmful effects of medications on disease progression, optimal strategies for treatment of cardiovascular disease in CKD and for early identification of kidney disease, and strategies for equitable access to care for patients with CKD. Conclusions: We identified the top 10 research priorities for patients with CKD that can be used to guide researchers, as well as inform funders of health-care research.
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I N T R O D U C T I O N
Similar to most other conditions, the chronic kidney disease (CKD) research agenda has traditionally been driven by investigators, as well as by commercial interests, resulting in studies that may not optimally inform patient care [1, 2] , or that fail to address the specific needs of those who are affected by the condition and make decisions about clinical care [3, 4] . The importance of engaging the broader stakeholder community in determining research priorities has been recognized, with increasing emphasis on patient-centered care, defined as care that is respectful of patient preferences and in which patient values guide clinical decisions [2] . Involving patients and their caregivers as key stakeholders in determining research priorities has been identified as being of key importance, with the goal of building partnerships in research and health care [5, 6] .
Despite the emphasis on patient-centered care and patient engagement, a recent systematic review [7] of research priority setting in kidney disease identified 16 studies that elicited patient, caregiver or health-care provider priorities for research in kidney disease, and of those only four (25%) explicitly involved patients, and only one included patients with early stages of CKD not yet on dialysis [8] . CKD care is sub-optimal [9, 10] , which may in part be due to lack of evidence that is relevant and important to patients with CKD, their caregivers, and the clinicians and policy-makers involved in their care [1, 2, 4] , or the mistaken perception that earlier stages of CKD are not clinically relevant [11] . While we recently completed a research priority setting exercise for patients on or nearing dialysis [12] , we did not consider the research uncertainties for patients with earlier stages of CKD.
Using the method established by the James Lind Alliance [13] , we aimed to identify the most important unanswered questions (or uncertainties) about the management of CKD (i.e. in terms of diagnosis, prognosis and treatment) from the perspective of adult patients with non-dialysis CKD, their caregivers, and the clinicians and policy-makers involved in the care of patients with CKD.
M A T E R I A L S A N D M E T H O D S
We used the James Lind Alliance process [13] to identify the top 10 research priorities, which involved four key steps: identification and invitation of potential partners; collection of research uncertainties through a national survey; refinement and prioritization of uncertainties to assemble a list of the top 30 uncertainties; and an in-person workshop to determine the top 10 research priorities. The final step was the basis for a randomized controlled trial comparing two methods of research prioritization (in-person nominal group technique and online wiki-based alternative). We report here the results of all four steps and the top 10 research priorities identified from the inperson workshop; the results of the randomized trial comparing the two methods of research prioritization will be reported separately. Ethics approval was obtained from the University of Calgary for the overall project, as well as from the sites that distributed paper-based surveys (University of Alberta, University of Manitoba and Western University).
Identification and invitation of potential partners
The priority setting process was initiated in July 2014 with the formation of a 12-person Steering Group from across Canada including patients with non-dialysis CKD, a caregiver, clinicians (nephrologists), researchers and an employee of the Kidney Foundation of Canada (non-for-profit organization for patients with kidney disease) (see www.CANN-NET.ca for a list of members). The Steering Group held bi-weekly conference calls from July 2014 to June 2015 to oversee the process.
Collection of research uncertainties through a national survey
We developed a survey to identify uncertainties, consisting of broad questions about the overall management of nondialysis CKD including diagnosis, prognosis and treatment issues (excluding treatment of kidney failure as that was addressed in our prior work) [12] . A taxonomy of issues relevant to CKD was created by the Steering Group to guide the development and scope of the survey, and to categorize survey responses. Patients with non-dialysis CKD [estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 m 2 ], caregivers, clinicians and policy-makers were invited to complete the online survey using the Fluid Surveys platform (Fluidware Inc., Ottawa, ON, Canada) through communications from our partner organizations (e.g. the Kidney Foundation of Canada), social media, and emails to members of the Canadian Society of Nephrology, the Canadian Association of Nephrology Nurses and Technologists, the Canadian Association of Dietitians and the Canadian Association of Nephrology Administrators. The online survey was open from 1 December 2014 to 6 February 2015. We also distributed paper-based surveys in four Canadian cities (Edmonton, AB; Calgary, AB; Winnipeg, MB; and London, ON) through their CKD clinics during the same time period. Finally, we searched the most recent clinical practice guidelines relevant to the care of patients with CKD not on dialysis to identify their recommendations for research.
Refinement and prioritization to determine top 30 uncertainties
The uncertainties identified by survey respondents (weband paper-based) and from guidelines were combined, and those deemed not relevant to adult patients with CKD (e.g. modality selection for renal replacement therapy, issues exclusive to pediatric patients) by two research team members (L.B. and B.R.H.) were eliminated. The same two research team members categorized the uncertainties within the taxonomy. For each of the 15 categories in the taxonomy, Steering Group members then worked in pairs (patient or caregiver paired with a clinician) to combine uncertainties into similar groups, with the goal of identifying a summary question (called an indicative question) for each group of uncertainties. This occurred over a series of two to four iterative meetings for each pair.
The next step in the process included the development of a summary document with all of the indicative questions, the original uncertainties that informed each of the indicative questions, and frequency counts (i.e. the number of times the uncertainty was identified by patients, caregivers and clinicians). This summary document was circulated to Steering Group members to facilitate an interim ranking exercise. Members of the Steering Group independently reviewed the indicative questions and ranked their top 30. The results were collated and provided back to the Steering Group. Over the course of three conference calls, the Steering Group discussed the indicative questions to achieve a consensus shortlist of 30 to be considered at the workshop that were reflective of the uncertainties from the survey, and the scope of the uncertainties identified and relevant to the care of patients with CKD.
Priority setting workshop
The final step in the process was a 1-day workshop that included 25 participants from across Canada, including 12 patients with non-dialysis CKD (eGFR <45 mL/min/1.73 m 2 ) and 6 caregivers, as well as 3 physicians, 2 nurses, 1 pharmacist and 1 policy-maker, all with experience in CKD. The Steering Group enlisted the support of nephrology networks, partner organizations and nephrologists from across Canada to identify potential participants for the workshop. Participants were
required to be a member of a stakeholder group: patients with CKD (eGFR <45 mL/min/1.73m 2 not on dialysis or with a prior transplant); informal caregivers of persons with CKD (relatives, family members or friends who help patients manage their illness); health-care professionals (primary care physicians, nephrologists, nurses, pharmacists, social workers or dietitians) who care for patients with CKD; or health policymakers (non-clinicians with the ability to influence or determine policies and practices related to health-care delivery for CKD). Individuals not eligible to participate included persons with an underlying diagnosis of dementia or cognitive impairment and patients deemed unfit to travel. A research assistant confirmed the eligibility of potential participants, described the study to them, and obtained their written informed consent. A nominal group technique approach was used at the workshop, with a combination of small and large group exercises [13] , facilitated by four individuals with prior experience in the James Lind Alliance process. A consensus approach (with voting when needed) was used to identify the top 10 research priorities.
R E S U L T S
Characteristics of survey respondents
In total, we received 2241 uncertainties from 439 respondents. The majority of respondents (272; 62%) were patients, with 37 (8%) caregivers and 112 clinicians/policy-makers involved in the care of patients with CKD [26%; of whom 28 (25%) were physicians, 35 (31%) were nurses and 12 (11%) were policy-makers]. The majority of patients were male (52.6%), <65 years of age (50%), Caucasian ethnicity (71.7%) and from western Canada (82.4%) ( Table 1) . Overall, 9.9% of patients were Aboriginal. Caregivers were predominantly female (73%) and <65 years of age (75.6%). Clinicians/policymakers were primarily 35-49 years of age, male, with an equal distribution from both eastern and western Canada.
Uncertainties
Of the 2241 uncertainties, 339 were removed by consensus because they were deemed not relevant to adult patients with CKD, and 91 were eliminated because the uncertainty was not clear (Figure 1 ). Fifteen uncertainties were added from clinical practice guidelines. Overall, there were 1826 in-scope uncertainties, the largest single group (18%) being related to diet, followed by management and treatment of CKD (13.6%) and CKD etiology and prevention (12.8%) ( Table 2) . From these 1826 in-scope uncertainties, we identified 148 indicative questions.
A summary document of the 148 indicative questions was prepared (including the number of times the uncertainty was identified by patients, caregivers and clinicians). Using consensus, the Steering Group, through a series of meetings as well as As not all of the demographic questions were mandatory, the categories do not all add to their respective denominators. 
Top 10 research priorities in non-dialysis CKD
The top 10 research priorities were identified at the workshop (Table 3 ). The top-ranked research priority was related to the most effective interventions and treatments to prevent the development and progression of kidney disease. The other questions included the best diet to slow progression, causes and treatment of symptoms (fatigue, low energy, sleeping problems, depression, anxiety and sexual dysfunction) of CKD, providerand patient-targeted strategies for managing CKD, the impact of lifestyle on disease progression, the harmful effects of medications on disease progression, optimal strategies for treatment of cardiovascular disease in CKD and for early identification of kidney disease, and finally strategies to ensure equitable access to care for patients with non-dialysis-dependent CKD. The uncertainties that were ranked 11-15 are identified in the Appendix.
D I S C U S S I O N
We identified the top 10 research priorities for patients with non-dialysis CKD, their caregivers, and the clinicians and policy-makers involved in their care, using an established methodology [13] . The research priorities included questions about the most effective interventions and treatments to prevent progression of kidney disease, the best diet to slow progression of kidney disease (including the benefits and risk of specific diets such as phosphate restriction and low salt) and the causes and best treatments for symptoms in patients with CKD (including fatigue, sleeping problems, depression, anxiety and sexual dysfunction).
Patient involvement in research priority setting in kidney disease is uncommon. The results of a recent systematic review [7] found 16 studies that elicited patient, caregiver or healthcare provider priorities for research in kidney disease. Upon further review, it was evident that only four of these studies explicitly involved patients, and only the study by Tong et al. [8] included patients with earlier stages of kidney disease not yet on dialysis. It is difficult to directly compare the results of our study with those of Tong et al., as patients in their study also included those with CKD either on dialysis or with a kidney transplant. However, similar to our work, the research priorities elicited included aspects of both primary prevention (reduce prevalence of CKD) and secondary prevention (prevent progression of CKD), emphasizing the importance for patients in identifying optimal ways to prevent or manage earlier forms of kidney disease, and thus avoid the need for dialysis. Both our study and the study by Tong et al. identified priorities to address the causes, and treatment strategies, for complications and symptoms of CKD.
Consistent with both our prior work to identify research priorities for patients with CKD on or nearing dialysis [12] and the study by Tong et al. [8] , we found that many uncertainties focused on symptoms experienced by patients with CKD, including a better understanding of the causes of the symptoms and development of effective treatments to improve quality of life. The symptoms most commonly identified by respondents to our survey included fatigue, sleeping problems, depression, anxiety and sexual dysfunction. In contrast, studies by Manns et al. [12] and Tong et al. [8] included symptoms of pruritus, nausea and vomiting, which are symptoms more common in patients with CKD on dialysis. This demonstrates that patients with earlier stages of kidney disease have a distinct set of symptoms.
In addition to symptoms, many of the research priorities focused on the prevention of CKD and strategies to slow the progression, rather than survival specifically, suggesting that patients with CKD are more concerned about their quality of life, rather than merely living longer. This is consistent with prior work suggesting that patients with CKD on dialysis are 
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willing to sacrifice survival for freedom to travel and prioritize caregiver respite [14, 15] . The research agenda to date has largely been driven by researchers, as well as by commercial interests [16, 17] , despite efforts to increase patient involvement in research for more than a decade [18, 19] . Recent studies continue to identify a critical gap between current research and what patients consider high priority [20, 21] , and provide evidence for the lack of patient engagement in research priority setting. The lack of patient voices in priority setting efforts may be partially attributable to the increased time and resources required for patient engagement [22] . Steps have been taken to ensure patient Source: mostly patients, but also some health professionals and caregivers Themes:
• How to prevent development of CKD • Need for new interventions and treatments to prevent progression of CKD • Interventions could include drug therapy (optimal medications to prevent CKD progression) (2) What is the best diet to slow progression of kidney disease and what are the benefits and risks of specific diets (i.e. phosphate restriction, protein restriction, low salt, etc.) in terms of kidney disease progression and quality of life?
Source: mostly patients, although a large number of health-care providers and some caregivers Themes:
• Uncertainties were related to the role that diet played in slowing kidney disease progression • Many patient uncertainties about the effectiveness of sodium and phosphate restriction on kidney health (3) What are the causes of symptoms in patients with chronic kidney disease, including fatigue, low energy, sleeping problems, depression, anxiety and sexual dysfunction, and how can these best be treated to improve quality of life?
Source: mostly patients Themes:
• Causes of fatigue and low energy • Impact of CKD on sexual function, and treatment options • Availability of improved treatments (4) What are the optimal strategies, such as having access to health information (e.g. lab test results), sharing of information and/or improving communication, to help patients manage their health condition(s) themselves and to improve patient experience and outcomes?
Source: mostly patients, with some health professionals and care providers Themes:
• Importance of empowering patients to manage their CKD • Need to identify specific strategies of importance and relevance to patients to enable their selfmanagement, such as access to their health information, test results, etc.
(5) What is the impact of lifestyle factors (i.e. exercise, stress) on risk of developing kidney disease, kidney disease progression and quality of life?
• Impact of exercise on slowing kidney disease progression • Impact of stress on progression of kidney disease • Need to identify other lifestyle changes that may delay kidney disease progression (6) What are the optimal strategies for the management of CKD (i.e. those undertaken by the primary care physician, nephrologist, other healthcare professionals) to delay progression and improve outcomes?
Source: mostly health-care professionals Themes:
• Strategies for primary care physicians to enhance CKD management in the community • Frequency of follow-up visits to provide optimal care
• Use of multidisciplinary care clinics to enhance CKD care
• Use of allied health-care professionals to provide CKD care (7) What are the harmful effects of medications used in patients with CKD, and in particular the combinations of medications used to treat other diseases (such as diabetes and high blood pressure)?
Source: mostly patients, with some health professionals Themes:
• Whether medications used to treat blood pressure, or use of diuretics for edema, can have adverse effects on the kidneys • Effect of diabetic medications (such as metformin) on kidney function and other adverse outcomes (8) What are the optimal approaches for the prevention and treatment of cardiovascular disease in patients with CKD?
• Which agent is optimal for blood pressure control in patients with CKD • Use of acetylsalicylic acid for primary or secondary prevention of cardiovascular disease in patients with CKD (9) What is the best strategy (e.g. screening, programs targeting high-risk groups, programs to increase public awareness) to identify kidney disease early?
• How to increase public awareness about kidney disease • How to best identify and target high-risk populations for screening for kidney disease • How can primary care providers incorporate early detection for CKD in high-risk groups into their routine care (10) How do we ensure that patients with CKD have equitable access to care (e.g. nephrologists, allied health clinics) irrespective of location of residence or socio-economic status?
Source: mostly patients, although some health professionals Themes:
• How to best provide equitable access to care for patients living in remote locations [24] . While in the UK, through INVOLVE, the National Institutes of Health Research developed a comprehensive strategy to support public involvement in research [6] .
The impact of patient involvement in research priority setting remains to be determined. There is evidence that patient involvement in health-care priority setting for chronic disease management can change priorities, and ultimately resulted in increased agreement between patients and providers [22] . The broad scope of the research priorities identified by patients and their providers can be used to inform a wide range of potential research activities, from basic science to population and public health. Reports from INVOLVE also indicate that patient involvement results in improvements in recruitment rates and a better understanding of patients' needs [25, 26] .
We used an established process, in a national setting, to determine the top 10 research priorities for patients with nondialysis CKD. The results of our study should, however, be interpreted in the light of its limitations. Although the process to elicit patient research priorities is relatively new, and may be criticized for results that potentially lack generalizability, we applied a structured and transparent method developed by the James Lind Alliance [13] , one of the three methods identified for priority setting in research by the Cochrane Agenda and Priority Setting Methods Group, and which has been successfully applied internationally in more than 13 chronic diseases [21] . Further, our survey to elicit research priorities was national in scope, and the demographics of respondents were similar to the general non-dialysis CKD population, suggesting that the results should be generalizable to other CKD populations in high-income countries. However, we do not know the stage of CKD among survey respondents, or the potential for selection bias due to the online option for completing the survey. While structured and transparent methods were applied, we recognize that the process includes participants' subjective views, and thus the intra-and inter-rater reliability of results cannot be guaranteed. There is also potential that health-care professionals at the workshop may influence the patient and caregiver responses. However, the use of the national survey, with an in-depth process of collating and categorizing the almost 2000 uncertainties, as well as the use of experienced facilitators at the workshop, should reduce the potential variability and ensure equal participation by all stakeholder groups.
Using an internationally accepted and transparent process involving patients with non-dialysis CKD, their caregivers, and the health-care professionals and policy-makers involved in the care of patients with CKD, we have identified the top 10 priorities for research. These research priorities can be used to guide researchers, as well as inform funders of health-care research, to ensure resources are invested to answer questions that are a shared priority.
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